Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-08-02 Sale |
2024-08-05 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $1,115 | $842,940 | 3,654 (Direct) |
View |
2024-08-01 Sale |
2024-08-05 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,137 | $1,061 | $1,206,198 | 13,105 (Indirect Direct) |
View |
2024-08-01 Sale |
2024-08-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
1 | $1,100 | $1,100 | 17,782 (Direct) |
View |
2024-08-01 Sale |
2024-08-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
99 | $1,086 | $107,467 | 17,783 (Direct) |
View |
2024-07-11 Sale |
2024-07-12 4:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,866 | $1,089 | $2,031,981 | 38,308 (Indirect Direct) |
View |
2024-07-01 Sale |
2024-07-02 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,137 | $1,047 | $1,190,564 | 14,242 (Indirect Direct) |
View |
2024-07-01 Sale |
2024-07-02 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $1,059 | $105,924 | 17,882 (Direct) |
View |
2024-06-24 Sale |
2024-06-25 4:41 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $1,062 | $802,872 | 4,410 (Direct) |
View |
2024-06-14 Sale |
2024-06-17 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,535 | $1,040 | $1,596,400 | 12,544 (Indirect Direct) |
View |
2024-06-11 Sale |
2024-06-13 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
25,213 | $1,016 | $25,610,229 | 2,355,926 (Indirect Direct) |
View |
2024-06-06 Sale |
2024-06-10 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
787 | $1,015 | $798,821 | 694,559 (Indirect Direct) |
View |
2024-06-05 Sale |
2024-06-07 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
827 | $1,011 | $836,097 | 1,382 (Direct) |
View |
2024-06-03 Sale |
2024-06-05 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,138 | $980.16 | $1,115,422 | 15,379 (Indirect Direct) |
View |
2024-06-03 Sale |
2024-06-05 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $994.5 | $99,450 | 17,982 (Direct) |
View |
2024-05-28 Sale |
2024-05-29 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,172 | $974.86 | $1,142,536 | 14,079 (Indirect Direct) |
View |
2024-05-21 Sale |
2024-05-22 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,865 | $994.9 | $1,855,489 | 38,416 (Indirect Direct) |
View |
2024-05-17 Sale |
2024-05-17 5:57 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
22,830 | $979.23 | $22,355,714 | 695,346 (Indirect Direct) |
View |
2024-05-16 Sale |
2024-05-17 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
50,000 | $972.73 | $48,636,545 | 1,148,844 (Indirect Direct) |
View |
2024-05-15 Sale |
2024-05-17 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
50,000 | $975.87 | $48,793,727 | 1,198,844 (Indirect Direct) |
View |
2024-05-14 Sale |
2024-05-15 6:10 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
35,941 | $979.58 | $35,207,110 | 718,176 (Indirect Direct) |
View |
2024-05-01 Sale |
2024-05-03 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
250 | $889.41 | $222,353 | 13,105 (Indirect Direct) |
View |
2024-05-01 Sale |
2024-05-03 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $899.61 | $89,961 | 18,082 (Direct) |
View |
2024-01-02 Sale |
2024-05-01 4:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
16,848 | $900 | $15,163,200 | 1,217,856 (Indirect Direct) |
View |
2024-04-01 Sale |
2024-04-03 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $962.53 | $96,253 | 18,182 (Direct) |
View |
2024-04-01 Sale |
2024-04-03 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
250 | $964.73 | $241,183 | 13,339 (Indirect Direct) |
View |
2024-03-14 Sale |
2024-03-15 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
5,783 | $956.47 | $5,531,290 | 72,616 (Indirect Direct) |
View |
2024-03-01 Sale |
2024-03-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $982.05 | $98,205 | 18,282 (Direct) |
View |
2024-03-01 Sale |
2024-03-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
358 | $967.5 | $346,365 | 13,589 (Indirect Direct) |
View |
2024-02-26 Sale |
2024-02-28 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,000 | $990 | $990,000 | 40,265 (Indirect Direct) |
View |
2024-02-26 Sale |
2024-02-28 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,000 | $992.5 | $992,500 | 33,837 (Indirect Direct) |
View |
2024-02-26 Sale |
2024-02-26 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
854 | $979.25 | $836,280 | 1,382 (Direct) |
View |
2024-02-22 Sale |
2024-02-26 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,000 | $967.65 | $967,650 | 41,265 (Indirect Direct) |
View |
2024-02-22 Sale |
2024-02-26 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
3,500 | $967.86 | $3,387,500 | 41,675 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-08-02 Exercise |
2024-08-05 4:05 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $0 | 3,654 (Direct) |
View |
2024-08-02 Exercise |
2024-08-05 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $371.4 | 3,654 (Direct) |
View |
2024-08-01 Exercise |
2024-08-05 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,137 | $372.46 | 13,105 (Direct) |
View |
2024-08-01 Exercise |
2024-08-05 4:04 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,137 | $0 | 13,105 (Direct) |
View |
2024-07-01 Exercise |
2024-07-02 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,137 | $372.46 | 14,242 (Direct) |
View |
2024-07-01 Exercise |
2024-07-02 4:01 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,137 | $0 | 14,242 (Direct) |
View |
2024-06-24 Exercise |
2024-06-25 4:41 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $0 | 4,410 (Direct) |
View |
2024-06-24 Exercise |
2024-06-25 4:41 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $371.4 | 4,410 (Direct) |
View |
2024-06-24 Exercise |
2024-06-25 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
14,450 | $555.67 | 54,624 (Direct) |
View |
2024-06-24 Tax Withholding |
2024-06-25 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
11,084 | $1,060 | 54,624 (Direct) |
View |
2024-06-24 Exercise |
2024-06-25 4:39 pm |
N/A 2025-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
14,450 | $0 | 54,624 (Direct) |
View |
2024-06-14 Exercise |
2024-06-17 4:01 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,535 | $0 | 12,544 (Direct) |
View |
2024-06-14 Exercise |
2024-06-17 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,535 | $625.6 | 12,544 (Direct) |
View |
2024-06-12 Conversion |
2024-06-13 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
1,000 | $0 | 2,355,926 (Indirect) |
View |
2024-06-10 Gift |
2024-06-12 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
113,699 | $0 | 1,110,945 (Indirect) |
View |
2024-06-10 Gift |
2024-06-12 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,608 | $0 | 36,808 (Indirect) |
View |
2024-06-05 Exercise |
2024-06-07 4:06 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
827 | $0 | 1,382 (Direct) |
View |
2024-06-05 Exercise |
2024-06-07 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
827 | $380.95 | 1,382 (Direct) |
View |
2024-06-03 Exercise |
2024-06-05 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,138 | $372.46 | 15,379 (Direct) |
View |
2024-06-03 Exercise |
2024-06-05 4:07 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,138 | $0 | 15,379 (Direct) |
View |
2024-05-28 Exercise |
2024-05-29 4:01 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,172 | $0 | 14,079 (Direct) |
View |
2024-05-28 Exercise |
2024-05-29 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,172 | $625.6 | 14,079 (Direct) |
View |
2024-05-13 Tax Withholding |
2024-05-15 6:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
144,433 | $976.79 | 718,176 (Direct) |
View |
2024-05-13 Exercise |
2024-05-15 6:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
203,204 | $399.66 | 718,176 (Direct) |
View |
2024-05-13 Exercise |
2024-05-15 6:10 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO |
203,204 | $0 | 718,176 (Direct) |
View |
2024-05-03 Exercise |
2024-05-06 4:20 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
2,000 | $413.33 | 32,960 (Direct) |
View |
2024-05-03 Exercise |
2024-05-06 4:20 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
2,000 | $0 | 32,960 (Direct) |
View |
2024-05-03 Tax Withholding |
2024-05-06 4:20 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
877 | $942.53 | 32,960 (Direct) |
View |
2024-04-29 Gift |
2024-05-01 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
54,444 | $0 | 1,248,844 (Indirect) |
View |
2024-03-13 Exercise |
2024-03-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $399.66 | 72,616 (Direct) |
View |
2024-03-13 Exercise |
2024-03-15 4:01 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $0 | 72,616 (Direct) |
View |
2024-03-13 Tax Withholding |
2024-03-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
14,217 | $971.82 | 72,616 (Direct) |
View |
2024-02-26 Exercise |
2024-02-28 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
500 | $413.33 | 33,837 (Direct) |
View |
2024-02-26 Exercise |
2024-02-28 4:04 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,000 | $0 | 33,837 (Direct) |
View |
2024-02-26 Gift |
2024-02-28 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
1,020 | $0 | 61,438 (Direct) |
View |
2024-02-26 Exercise |
2024-02-26 4:07 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
854 | $0 | 1,382 (Direct) |
View |
2024-02-26 Exercise |
2024-02-26 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
854 | $391.92 | 1,382 (Direct) |
View |
2024-02-22 Exercise |
2024-02-26 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,500 | $413.33 | 41,675 (Direct) |
View |
2024-02-22 Exercise |
2024-02-26 4:07 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
3,500 | $0 | 41,675 (Direct) |
View |
2024-02-15 Tax Withholding |
2024-02-20 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
123,601 | $953.83 | 1,266,978 (Direct) |
View |
2024-02-15 Exercise |
2024-02-20 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
172,723 | $399.66 | 1,266,978 (Direct) |
View |
2024-02-15 Exercise |
2024-02-20 4:03 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
172,723 | $0 | 1,266,978 (Direct) |
View |